@Terminalxylem (and others who might want to tackle this)... a couple quick questions about mutations:
1) Regarding the South African variant now prevalent in the UK and spreading here. Is it still assumed that this vaccine will be similarly effective against this strain?
2) What is the likelihood (in your professional opinion) we'll be looking at a mutation that moves outside protection from this vaccine?
3) IF such a mutation occurs, what sort of timeline (realistically) are we looking at to creating a modified/new vaccine that will be administerable. I know sequencing can be done lightning fast now, but how would testing/approval and other red tape go? Manufacturing timelines, etc?
TIA